Missing 3 days
We are counting down to the 10th Lung Cancer Study Group Congress / 1st Portuguese Lung Cancer Congress.In the words of Dr. Teresa Almodovar, president of GECP, this event “will last for three full days, with a space dedicated to…
N E W S - A R C H I V E
- webinar
- vídeo
- tabacco
- GECP magazine
- reunião
- repórter GECP
- questionário
- publicações
- patrocinado
- passatempo
- parceiros
- PAP
- OFF
- news
- mídia
- entrevista
- curso
- cuidadores
- covid-19
- congresses
- campanha
- caminhada
- artigo escolhido
- artigo cientifico
- #ocancrodopulmaonaomedefine
- Campanha #EnfermeiroComOrgulho
New Journals of the Lung Cancer Study Group
The Journal of the Lung Cancer Study Group, Vol. XIX, nº2 of 2021, is now available for consultation and free download here! Access https://www.gecp.pt/revistas/ to consult this edition and other issues from previous years of Revista do GECP And if…
10th GECP Congress
The 10th GECP Congress, which opens the Portuguese Lung Cancer Congress, will take place on the 20th, 21st and 22nd of October, in Troia, in an entirely face-to-face format. In this event, under the theme “Lugar ao Novo”, “we will…
Don’t Play With Your Life: Lung Cancer Is Not a Game
“Don’t gamble with your life” is the alert from the Lung Cancer Study Group (GECP) on the occasion of the International Gamer Day, celebrated annually on August 29, with the aim of putting the topic of lung cancer on the…
Men Made Cancer
Men Made Cancer: “Lung cancer is the biggest killer, but its main risk factors are modifiable” “Men Made Cancer” is the motto of the new campaign by the Lung Cancer Study Group (GECP) for World Lung Cancer Day, which is…
Tecentriq (atezolizumab) gets Infarmed approval for new indications
The drug Tecentriq (atezolizumab) obtained authorization from the National Authority for Medicines and Health Products (Infarmed) to be used in hospitals in new indications for the treatment of lung cancer. According to the grant recently published on the Infarmed website,…
Chosen Article
Dr. Fernanda EstevinhoOncologist at Hospital Pedro Hispano – ULS MatosinhosSelected Article: “Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data” O artigo selecionado…
Today marks World Social Media Day
To celebrate this anniversary, we recall the GECP’s journey through the most used digital communication networks around the world.After our debut on Facebook and Instagram in May 2020, we created an institutional page on LinkedIn last year.At a time when…
World No Tobacco Day
Lung cancer is more than smoking” is the motto of the GECP campaign to mark the World No Tobacco Day, which is celebrated annually on the 31st of May.Today we focus on demystifying the stigma associated with lung cancer, warning…
New: Discover the “Selected Item” Rubric
GECP has just launched another digital initiative that aims to promote regular scientific updating and the sharing of ideas among peers. It is entitled “Selected Article” and gives voice to the members of the Scientific Committee of the GECP, inviting…
Lung cancer: few symptoms make diagnosis difficult
As part of the webinar “Lung Cancer: together for a more promising future”, a group of representatives from the Portuguese Pneumology Society (Prof. Dr. António Morais), from the Lung Cancer Study Group (Dr. Teresa Almodovar), from the Portuguese League Against…
Today marks the European Day of Oncology Nursing!
On May 18, to mark the European Oncology Nursing Day, the Lung Cancer Study Group (GECP) and the Portuguese Oncology Nursing Association (AEOP) launched a tribute campaign to all oncologist nurses. To celebrate this date, we invited three nurses to…